| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |